pityriasis simplex
MONDO:0024343
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
MONDO disease family
Recruiting studies by city
Trial status
Trial phase
Study start year
Investigated drug interventions
Dandruff
Dandruff is a skin condition of the scalp. Symptoms include heavy flaking and sometimes mild itchiness. It can result in social or self-esteem problems. A more severe form of the condition, which includes inflammation of the skin, is known as seborrhoeic dermatitis. The cause is unclear, but believed to involve a number of genetic and environmental factors; the condition may worsen in the winter. It is not due to poor hygiene, and the underlying mechanism involves the excessive growth of skin cells. Diagnosis is based on symptoms. There is no known cure for dandruff. Antifungal cream, such as ketoconazole, or the keratolytic agent salicylic acid may be used to try to improve the condition. Dandruff affects about half of adults, with males more often affected than females. In addition, people in all areas of the world are affected. Onset is usually at puberty, and it becomes less common after the age of 50.
Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.Drugs being studied
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.